144 related articles for article (PubMed ID: 16459066)
1. The role of stroma in immune recognition and destruction of well-established solid tumors.
Yu P; Rowley DA; Fu YX; Schreiber H
Curr Opin Immunol; 2006 Apr; 18(2):226-31. PubMed ID: 16459066
[TBL] [Abstract][Full Text] [Related]
2. Targeting the stroma by T cells to limit tumor growth.
Zhang B
Cancer Res; 2008 Dec; 68(23):9570-3. PubMed ID: 19047130
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic modulation of lymphocyte function by stromal cell network: advance in therapeutic targeting of cancer.
Görgün G; Anderson KC
Immunotherapy; 2011 Oct; 3(10):1253-64. PubMed ID: 21995575
[TBL] [Abstract][Full Text] [Related]
4. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
5. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
6. Immune cells as mediators of solid tumor metastasis.
DeNardo DG; Johansson M; Coussens LM
Cancer Metastasis Rev; 2008 Mar; 27(1):11-8. PubMed ID: 18066650
[TBL] [Abstract][Full Text] [Related]
7. B7.1/NHS76: a new costimulator fusion protein for the immunotherapy of solid tumors.
Liu A; Hu P; Khawli LA; Epstein AL
J Immunother; 2006; 29(4):425-35. PubMed ID: 16799338
[TBL] [Abstract][Full Text] [Related]
8. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.
Katou F; Ohtani H; Watanabe Y; Nakayama T; Yoshie O; Hashimoto K
Cancer Res; 2007 Dec; 67(23):11195-201. PubMed ID: 18056444
[TBL] [Abstract][Full Text] [Related]
9. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
Xia D; Moyana T; Xiang J
Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
[TBL] [Abstract][Full Text] [Related]
10. Equilibrium between host and cancer caused by effector T cells killing tumor stroma.
Zhang B; Zhang Y; Bowerman NA; Schietinger A; Fu YX; Kranz DM; Rowley DA; Schreiber H
Cancer Res; 2008 Mar; 68(5):1563-71. PubMed ID: 18316622
[TBL] [Abstract][Full Text] [Related]
11. Le morte du tumour: histological features of tumor destruction in chemo-resistant cancers following intravenous infusions of pathotropic nanoparticles bearing therapeutic genes.
Gordon EM; Chan MT; Geraldino N; Lopez FF; Cornelio GH; Lorenzo CC; Levy JP; Reed RA; Liu L; Hall FL
Int J Oncol; 2007 Jun; 30(6):1297-307. PubMed ID: 17487349
[TBL] [Abstract][Full Text] [Related]
12. Cancer immunologists and cancer biologists: why we didn't talk then but need to now.
Prendergast GC; Jaffee EM
Cancer Res; 2007 Apr; 67(8):3500-4. PubMed ID: 17413003
[TBL] [Abstract][Full Text] [Related]
13. The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts.
Tzukerman M; Rosenberg T; Reiter I; Ben-Eliezer S; Denkberg G; Coleman R; Reiter Y; Skorecki K
Cancer Res; 2006 Apr; 66(7):3792-801. PubMed ID: 16585206
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of fibroblast activation protein in patients with colon cancer.
Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
[TBL] [Abstract][Full Text] [Related]
15. Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses.
de Souza AP; Bonorino C
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1317-32. PubMed ID: 19761435
[TBL] [Abstract][Full Text] [Related]
16. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Man S; Munoz R; Kerbel RS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment: the role of the tumor stroma in cancer.
Li H; Fan X; Houghton J
J Cell Biochem; 2007 Jul; 101(4):805-15. PubMed ID: 17226777
[TBL] [Abstract][Full Text] [Related]
18. [Immune response and cancer].
El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous fusion with, and transformation of mouse stroma by, malignant human breast cancer epithelium.
Jacobsen BM; Harrell JC; Jedlicka P; Borges VF; Varella-Garcia M; Horwitz KB
Cancer Res; 2006 Aug; 66(16):8274-9. PubMed ID: 16912208
[TBL] [Abstract][Full Text] [Related]
20. Immunology and breast cancer: therapeutic cancer vaccines.
Curigliano G; Rescigno M; Goldhirsch A
Breast; 2007 Dec; 16 Suppl 2():S20-6. PubMed ID: 17706425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]